Leukemia down arrow

Home > Disclaimer > Leukemia > AML

 

Acute Myeloid Leukemia

 

 

Late Effects

 

Long term survivors of AML have chronic health risks related to their previous therapy:

 

Chemotherapy related long-term complication in survivors of AML:

Chemotherapy Agent

Long Term Effect

Daunorubicin

Cardiomyopathy

  • Dose dependent

 

VP16

(also called Etoposide)

 

 

The most serious late effects in survivors of AML occur in those treated with bone marrow transplant.

There are many long term health risks after BMT. In one single institution review there was a very high incidence of late effects in survivors of AML - but these were largely related to transplant (Leung et al).

Please follow these links:

 

External link:

AML Survivorship and Adverse Late Sequelae at the National Cancer Institute

 

 

Back to top

Next